Convergence Radar Convergence Engine

← Feed

A

340B RebateFiler β€” rebate-claim assembly & reconciliation SaaS for the HRSA 340B Rebate Model Pilot

75/100

A submission-and-reconciliation layer that lets 340B covered entities assemble, match, submit, and audit rebate claims into HRSA's new 340B rebate system β€” priced per claim/per seat.

Build immediately β€” high demand, fast revenue, solo feasible. Β· created 2026-07-11 03:16 UTC

public recordssaasapifast cashagentlong-term

Scorecard

newness 9/10
convergence 9/10
demand evidence 9/10
existing spend 8/10
solo feasibility 6/10
speed to mvp 6/10
speed to revenue 6/10
distribution 7/10
competitive gap 7/10
expansion 8/10
founder fit 9/10

Opportunity brief

What changed
HRSA filed a Paperwork Reduction Act ICR (published 2026-06-15, OMB Notice 2026-11989) for the new 340B Rebate Model Pilot Program, and issued a correction 2026-06-22 raising the estimated total responses from 793,080 to 793,091 to include 11 manufacturer Pilot Program Plans. FACT from the two Federal Register notices provided.
Why now
The ICR is in its 30-day comment period and OMB can only act after it closes β€” a new HRSA 340B rebate system and a defined filing burden are being stood up now, before any tooling ecosystem exists. FACT that a 30-day comment period and new portal are described; HYPOTHESIS that no incumbent tool yet targets this specific pilot workflow.
Converging signals
Three signals meet at one point: (1) a new federal rule/ICR, (2) a defined forced-filer class (340B covered entities: hospitals, clinics, FQHCs + 11 manufacturers), and (3) a new HRSA rebate portal receiving ~793,091 responses/yr. This is the founder's canonical public-money/forced-filer shape.
Customer pain
340B rebate claims require matching dispensed drugs to eligible patients/manufacturers, assembling claim data, submitting on deadline, and surviving audit/reconciliation against manufacturer disputes. Under a rebate (vs. upfront-discount) model, entities must front the cost and reclaim it β€” cash-flow and reconciliation risk is real. HYPOTHESIS on the operational specifics (not stated in source text); the ~793k response count is FACT and implies high recurring paperwork volume.
Who pays
340B covered entities β€” FQHCs, disproportionate-share hospitals, Ryan White and other grantee clinics β€” and possibly the third-party administrators (TPAs) and 340B consultants who already service them per-claim. Reachable, non-procurement buyers who file continuously.
Solved today
Existing 340B TPAs (Apexus-adjacent vendors, split-billing software) handle contract-pharmacy accumulation today, but the rebate MODEL is new; entities will lean on consultants/TPAs billing per-claim or a percentage. HYPOTHESIS β€” no rebate-pilot-specific tool is named in source.
Why current solutions are bad
Incumbent 340B TPAs are built for the upfront-discount split-billing model, not a manufacturer-rebate claim/reconcile/audit flow into a brand-new HRSA portal; consultant fees scale with claim volume. A purpose-built submission+reconciliation tool undercuts the fee and closes the portal-integration gap.
Proposed product
A micro-SaaS that (1) ingests an entity's dispensing/claim data, (2) matches each claim to the correct participating manufacturer and rebate eligibility rules, (3) assembles the HRSA-format rebate claim and Program Plan submissions, (4) submits to the HRSA 340B rebate system, and (5) maintains an immutable audit trail + reconciliation dashboard against manufacturer responses.
MVP version
Start with claim assembly + validation + audit-trail export for a single covered-entity pilot participant: import claim CSV/EDI, run manufacturer-match and eligibility checks, output a portal-ready submission package and audit log. Add direct portal submission once HRSA publishes the system spec.
30-day build
Read the full ICR + supporting statement (once posted to reginfo.gov), file a comment to get on HRSA's radar and learn the data schema, map the exact fields of the rebate claim and Program Plan forms, and interview 5-10 FQHC/hospital 340B coordinators and a 340B consultant to confirm the reconciliation pain and willingness to pay.
60-day build
Build the claim-assembly + manufacturer-match + validation + audit-trail engine against the published form fields; recruit 2-3 design-partner covered entities from the pilot cohort; produce a reconciliation dashboard mock validated with them.
90-day revenue plan
Onboard first paying design partners at a per-claim or monthly-seat price for assembly/validation/audit before live portal submission opens; convert to per-filing pricing when HRSA's system goes live. First revenue realistically 90-180 days given the pilot's own timeline β€” acceptable under the founder's capital/runway.
Distribution path
Direct outreach to the finite, listed 340B covered-entity universe (HRSA's 340B OPAIS database is public β€” every covered entity is enumerable) and to 340B consultants/TPAs as a white-label reconciliation layer; publish a comment + a plain-English 'what the rebate pilot means for your claims' explainer as inbound.
Pricing hypothesis
Per-claim fee (e.g., $0.25-$1.00/claim) or per-entity monthly seat ($300-$1,500/mo) undercutting percentage-of-rebate consulting; upsell reconciliation/audit tier.
Technical difficulty
Moderate β€” data matching, validation, and audit logging are squarely in the founder's wheelhouse (mirrors his FMCSA ELDT portal-submission app). The unknown is the HRSA rebate system's submission interface, which is not yet published.
Legal / regulatory risk
Low-moderate: handling PHI-adjacent dispensing data implies HIPAA business-associate obligations (BAA + safeguards) β€” a real compliance cost, but compliance-as-moat, not a licensing barrier for the founder himself.
Platform dependency
None in the deplatform sense β€” it submits to a government system with no private platform owner. Dependency is on HRSA publishing a stable submission spec/API.
Founder fit
Very high. This is the exact shape he has already shipped (FMCSA ELDT: read a federal mandate β†’ identify forced filers β†’ build portal-submission layer β†’ charge per filing). Public records + systems thinking + government-portal integration all apply.
Breakout potential
High if the pilot expands to the full 340B program (thousands of entities, tens of millions of claims). Risk: pilot could be delayed, altered, or litigated (340B rebate models are politically contested).
Final recommendation
PURSUE, staged. Highest-tier founder-fit and a hard forced-buyer signal (793,091 estimated annual responses is FACT-level demand). De-risk by starting with the offline claim-assembly/validation/audit product (no portal dependency), landing pilot design partners, and adding live submission the moment HRSA publishes the system. Watch for pilot delay/litigation before over-investing.
Next action
Pull the full ICR supporting statement from reginfo.gov (OMB control number in Notice 2026-11989), extract the exact rebate-claim and Program-Plan data fields, and interview 5 covered-entity 340B coordinators + one 340B consultant to confirm reconciliation pain and per-claim willingness to pay.

Kill arguments (adversarial)

Competitors

β€’ 340B TPAs (split-billing/contract-pharmacy vendors, e.g. Apexus-ecosystem) (link) β€” Built for the upfront-discount split-billing model; rebate-model claim/reconciliation is a new adjacent workflow they may extend into β€” the incumbency risk to watch.
β€’ 340B consultants β€” Bill per-claim or percentage-of-rebate; their fee is the wedge to undercut, and they are also a potential white-label channel.

Source citations (facts)

β€’ HRSA ICR: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation β€” PRA ICR submitted to OMB listing 793,080 total estimated responses; OMB may act only after the 30-day comment period closes.
β€’ 340B Rebate Model Pilot Program β€” Correction β€” Corrects total estimated responses to 793,091 to include the 11 manufacturer Pilot Program Plans; names covered entities and 11 manufacturers as filers.

Actions